Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythropoietin: from bench to bedside.

J L Spivak1

  • 1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205.

Transactions of the American Clinical and Climatological Association
|January 1, 1990
PubMed
Summary

Erythropoietin, a hormone regulating red blood cells, shows a complex relationship with hemoglobin levels, especially in disease states. Its production is tightly controlled to manage red blood cell mass and meet specific demands of developing red blood cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The polycythemia vera stem cell.

Leukemia supplements·2016
Same author

The quantitative JAK2 V617F neutrophil allele burden does not correlate with thrombotic risk in essential thrombocytosis.

Leukemia·2007
Same author

The third International Congress on Myeloproliferative and Myelodysplastic Syndromes.

Leukemia research·2006
Same author

The second international congress on myeloproliferative and myelodysplastic syndromes.

Leukemia research·2004
Same author

Erythropoietin use and abuse: When physiology and pharmacology collide.

Advances in experimental medicine and biology·2002
Same author

A mail survey of United States hematologists and oncologists: a comparison of business reply versus stamped return envelopes.

Journal of clinical epidemiology·2001

Area of Science:

  • Hematology
  • Endocrinology
  • Molecular Biology

Background:

  • Erythropoietin (EPO) is a unique hematopoietic growth factor with hormonal properties.
  • Sensitive immunoassays have enabled closer examination of EPO physiology.
  • A known inverse correlation exists between EPO and hemoglobin levels.

Purpose of the Study:

  • To investigate the intricate regulation of erythropoietin production and its physiological implications.
  • To explore how disease states affect erythropoietin response.
  • To understand the interaction between erythropoietin and erythroid progenitor cells.

Main Methods:

  • Utilized sensitive immunoassays to measure erythropoietin levels.
  • Analyzed the relationship between erythropoietin and hemoglobin across different physiological and pathological conditions.
  • Examined erythropoietin's effects on erythroid progenitor cells in vitro.

Main Results:

  • The inverse correlation between erythropoietin and hemoglobin is confirmed but is tightly regulated and primarily observed below a specific hemoglobin threshold.
  • Certain diseases impair the erythropoietin-producing cells' response to anemia, potentially due to threshold resetting or a dichotomy in gene expression and protein synthesis.
  • Erythropoietin production is tightly regulated to prevent excessive red blood cell mass increases and to match the demands of erythroid progenitor cells.

Conclusions:

  • Erythropoietin acts as a hormone with complex regulatory mechanisms influencing red blood cell production.
  • Disease states can significantly alter erythropoietin production and response, highlighting the need for further investigation into these mechanisms.
  • The study underscores the importance of precise erythropoietin levels for normal erythropoiesis, with sustained high levels not always required for desired effects on progenitor cells.

Related Experiment Videos